$86.33
1.52% yesterday
Nasdaq, Jun 27, 10:06 pm CET
ISIN
US2521311074
Symbol
DXCM
Sector

DexCom, Inc. Stock price

$86.33
+1.00 1.17% 1M
+6.09 7.59% 6M
+8.56 11.01% YTD
-28.21 24.63% 1Y
+9.73 12.70% 3Y
-13.22 13.28% 5Y
+66.56 336.56% 10Y
+83.34 2,789.71% 20Y
Nasdaq, Closing price Fri, Jun 27 2025
+1.29 1.52%
ISIN
US2521311074
Symbol
DXCM
Sector

Key metrics

Basic
Market capitalization
$33.9b
Enterprise Value
$33.7b
Net debt
$-200.5m
Cash
$2.7b
Shares outstanding
392.1m
Valuation (TTM | estimate)
P/E
66.41 | 41.72
P/S
8.16 | 7.19
EV/Sales
8.11 | 7.15
EV/FCF
58.50
P/B
14.93
Financial Health
Equity Ratio
32.43%
Return on Equity
27.40%
ROCE
17.03%
ROIC
12.83%
Debt/Equity
1.10
Financials (TTM | estimate)
Revenue
$4.1b | $4.7b
EBITDA
$857.8m | $1.4b
EBIT
$632.6m
Net Income
$535.2m | $811.4m
Free Cash Flow
$575.2m
Growth (TTM | estimate)
Revenue
9.11% | 16.74%
EBITDA
1.10% | 56.22%
EBIT
-2.92%
Net Income
-16.28% | 40.82%
Free Cash Flow
-1.42%
Margin (TTM | estimate)
Gross
60.72%
EBITDA
20.68% | 28.91%
EBIT
15.25%
Net
12.90% | 17.23%
Free Cash Flow
13.87%
More
EPS
$1.30
FCF per Share
$1.47
Short interest
3.06%
Employees
10.25k
Rev per Employee
$390.00k
Show more

Create a Free Account to create an DexCom, Inc. alert.

Set up alerts on Stock Price, Dividend Yield, Valuation (e.g. P/E or EV/Sales) or Strategy Scores and sit back and relax.

DexCom, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

33 Analysts have issued a DexCom, Inc. forecast:

28x Buy
85%
5x Hold
15%

Analyst Opinions

33 Analysts have issued a DexCom, Inc. forecast:

Buy
85%
Hold
15%

Financial data from DexCom, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
4,148 4,148
9% 9%
100%
- Direct Costs 1,629 1,629
17% 17%
39%
2,519 2,519
5% 5%
61%
- Selling and Administrative Expenses 1,277 1,277
6% 6%
31%
- Research and Development Expense 556 556
5% 5%
13%
858 858
1% 1%
21%
- Depreciation and Amortization 225 225
14% 14%
5%
EBIT (Operating Income) EBIT 633 633
3% 3%
15%
Net Profit 535 535
16% 16%
13%

In millions USD.

Don't miss a Thing! We will send you all news about DexCom, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

DexCom, Inc. Stock News

Neutral
Business Wire
10 days ago
SAN DIEGO--(BUSINESS WIRE)--DexCom, Inc., the global leader in glucose biosensing, today released its "Dexcom State of Type 2 Report: Access and Attitudes Across the United States" ahead of the 85th Scientific Sessions of the American Diabetes Association (ADA) in Chicago. The findings provide valuable insights into the perceptions around diabetes technology from more than 400 healthcare profes...
Neutral
Business Wire
18 days ago
SAN DIEGO--(BUSINESS WIRE)--Johnson Fistel, PLLP, a leading stockholder rights law firm, has initiated an investigation into the board members and executive officers of DexCom, Inc. (NASDAQ: DXCM) for potential breaches of fiduciary duties and violations of the federal securities laws. What is Johnson Fistel Investigating? Between April 28, 2023 and June 5, 2024, certain DexCom insiders caused ...
Neutral
GlobeNewsWire
23 days ago
SAN DIEGO, June 05, 2025 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP, a leading stockholder rights law firm, has initiated an investigation into the board members and executive officers of DexCom, Inc. (NASDAQ: DXCM) for potential breaches of fiduciary duties and violations of the federal securities laws.
More DexCom, Inc. News

Company Profile

DexCom, Inc. is a medical device manufacturing company. The firm engages in the design, development and commercialization of glucose monitoring systems for ambulatory use by people with diabetes. Its products include Dexcom G4 PLATINUM System, DexCom G5 Mobil, DexCom Share and Mobile apps. The company was founded by John F. Burd on May 1, 1999 and is headquartered in San Diego, CA.

Head office United States
CEO Kevin Sayer
Employees 10,250
Founded 1999
Website www.dexcom.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today